Related Experiment Video

Updated: May 28, 2026

The Goeckerman Regimen for the Treatment of Moderate to Severe Psoriasis
11:39

The Goeckerman Regimen for the Treatment of Moderate to Severe Psoriasis

Published on: July 11, 2013

Procedures and drugs in pediatric dermatology: iatrogenic risks and situations of concern

Kalpana Reddy1, Sophia Kogan, Sharon A Glick

  • 1Department of Dermatology, SUNY Downstate Medical Center, 450 Clarkson Avenue, Box 46, Brooklyn, NY 11203, USA.

Clinics in Dermatology
|October 22, 2011
PubMed

Insights

Pediatric iatrogenic skin injuries, though reduced by technology, still affect vulnerable children. This review details the risks, presentation, and management of these injuries in pediatric patients.

Area of Science:

  • Pediatric dermatology
  • Neonatal care
  • Hospital-acquired conditions

Background:

  • Improved medical technologies have decreased but not eliminated iatrogenic injuries in pediatric patients.
  • Neonates (younger than 32 weeks gestational age), premature infants, and those with prolonged hospital stays are at high risk.
  • Older children with compromised skin barriers due to infections, inflammatory conditions, or blistering disorders are also susceptible.

Purpose of the Study:

  • To review the presentation, course, and management of iatrogenic skin injuries in pediatric populations.
  • To identify key risk factors associated with iatrogenic cutaneous injury in children.
  • To provide insights into the clinical aspects and treatment strategies for these injuries.

Main Methods:

  • Literature review focusing on iatrogenic skin injuries in pediatric patients.
  • Analysis of risk factors including gestational age, birth weight, and indwelling devices.
  • Examination of patient populations with compromised skin barriers.

Main Results:

  • Iatrogenic skin injuries remain a concern in pediatric care despite technological advancements.
  • Immature skin barriers in neonates and compromised barriers in older children are significant risk factors.
  • Specific conditions like staphylococcal scalded skin syndrome and atopic dermatitis increase vulnerability.

Conclusions:

  • Understanding high-risk pediatric populations is crucial for preventing iatrogenic skin injuries.
  • Prompt recognition and appropriate management are essential for improving outcomes.
  • Further research and preventative strategies are needed to minimize these adverse events.

More Related Videos

A Standardized Procedure of Dressing Management for Toxic Epidermal Necrolysis07:22

A Standardized Procedure of Dressing Management for Toxic Epidermal Necrolysis

Published on: March 14, 2025

Resolving Water, Proteins, and Lipids from In Vivo Confocal Raman Spectra of Stratum Corneum through a Chemometric Approach09:32

Resolving Water, Proteins, and Lipids from In Vivo Confocal Raman Spectra of Stratum Corneum through a Chemometric Approach

Published on: September 26, 2019

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Acne Infection01:27

Acne Infection

Acne is a multifactorial skin condition primarily affecting adolescents and young adults, with a global prevalence estimated to exceed 75% in this demographic. The condition is characterized by the formation of comedones (blackheads and whiteheads), papules, pustules, nodules, and, in severe cases, cysts, particularly in areas rich in sebaceous glands such as the face, neck, chest, and back. The pathogenesis involves increased sebum production, follicular hyperkeratinization, colonization by...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...